chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 10.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a nurse concerning her 10 year old daughter with eczema and who had been immunosuppressed, was vaccinated "5 years ago" in 2002, with varicella virus vaccine live (Oka/Merck). Subsequently, the patient experienced four chickenpox episodes after receiving the varicella virus live vaccine (Oka/Merck). Each episode occurred about a year apart from each other, and the chickenpox appeared only on the patient's trunk area. The patient saw her physician, specific treatment not reported. The patient has recovered. A product quality complaint was not reported. No further information was available. Follow up information from the physician provided no further information. Additional information is not expected.
Sex: M
Vaccine: VARCEL
Symptoms: Injection site rash
Clinical narrative: Information has been received from a physician concerning a male who was vaccinated with varicella virus vaccine live (Oka/Merck). Subsequently, the patient experienced a rash around the injection site. The patient sought medical attention and has recovered. No product quality complaint was reported. Additional information was not available. Follow up information from the physician indicated that they did not recall an event and were unable to provide additional patient information. Additional information has been requested.
Age: 1.2
Sex: M
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a physician concerning a 4-year-old male who on 27-MAY-2004 was vaccinated subcutaneously in the left arm  with a first dose of varicella virus vaccine live (Oka/Merck) (lot# 647265/1097N). On 19-OCT-2007, the patient developed breakthrough chickenpox with a rash and 20 lesions on the trunk and upper arms. There was no fever. It was reported that no medical attention was sought. No outcome was reported. Follow-up information indicated that the patient sought medical attention with a doctor's visit. Around 24-Oct-2007 the patient recovered. This is one of several reports from the same reporter. Additional information is not expected.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a pharmacist concerning a patient who was vaccinated with the second dose of varicella virus vaccine live (Oka/Merck) and experienced breakthrough chicken pox. The patient's outcome was not reported. No further information is available.
Sex: U
Vaccine: VARCEL
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a nurse practitioner concerning a patient who on 24-OCT-2007 was vaccinated with varicella virus vaccine live (Oka/Merck) instead of zoster vaccine live (Oka/Merck). The nurse reports the products were stored in the wrong spot in the office and varicella virus vaccine live (Oka/Merck) was given inadvertently. She does not feel that this was product confusion it was a case of human error. No adverse events reported. A product quality complaint was not involved. This is one of several reports from the same source. Additional information has been requested.
Age: 33.0
Sex: F
Vaccine: VARCEL
Symptoms: Antibody test negative, Varicella zoster serology negative
Clinical narrative: Information has been received from a registered nurse concerning a 33-year-old female with no known drug a history of depression, fibrous dysplasia of bone, hip surgery and femur surgery who in 1994 was vaccinated with one or two doses of varicella virus vaccine live (Oka/Merck). On 02-FEB-2007, a varicella immunoglobulin titer reported no immunity to varicella. Medical attention was sought at the physician's office. The outcome was reported as not recovered. No product quality complaint was involved. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: Information has been received from a nurse practitioner concerning a patient who on 24-OCT-2007 was vaccinated with varicella virus vaccine live (Oka/Merck) instead of zoster vaccine live (Oka/Merck). The nurse reports the products were stored in the wrong spot in the office and varicella virus vaccine live (Oka/Merck) was given inadvertently. She does not feel that this was a product confusion, it was a case of human error. No adverse events reported. A product quality complaint was not involved. This is one of several reports from the same source. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: Information has been received from a nurse practitioner concerning a patient who on 24-OCT-2007 was vaccinated with varicella virus vaccine live (Oka/Merck) instead of zoster vaccine live (Oka/Merck). The nurse reports the products were stored in the wrong spot in the office and varicella virus vaccine live (Oka/Merck) was given inadvertently. She does not feel that this was product confusion it was a case of human error. No adverse events reported. A product quality complaint was not involved. This is one of several reports from the same source. Additional information has been requested.
Age: 4.0
Sex: U
Vaccine: VARCEL
Symptoms: Erythema, Immediate post-injection reaction
Clinical narrative: Information has been received from a physician concerning a memo from their corporate office regarding a four year old patient who had received varicella virus vaccine live (Oka/Merck) booster and immediately experienced facial red spots. It was reported that he was administered emergency Benadryl and stabilized. Current patient status was not reported. No product quality complaint was reported. Further information was not available. This is one of three reports from the same source. Additional information has been requested.
Age: 4.0
Sex: U
Vaccine: VARCEL
Symptoms: Erythema, Immediate post-injection reaction
Clinical narrative: Information has been received from a physician concerning a 4-year-old who was vaccinated on an unspecified date with a dose of varicella virus vaccine live (Oka/Merck). Immediately, the patient developed facial red spots. Benadryl was given and the patient was stabilized. No other information was available. This event not occur at the reporting physicians office. This is one of several reports from the same reporter. Additional information has been requested.
Age: 9.0
Sex: U
Vaccine: FLUN3, VARCEL
Symptoms: Dyspnoea, Face oedema, Livedo reticularis, Wheezing
Clinical narrative: Information has been received from a physician concerning a 9-year-old child who was vaccinated on an unspecified date with varicella virus vaccine live (Oka/Merck). Concomitant vaccination included influenza virus 3v reassortant vaccine live intranasal (cold adapted Ann Arbor master strain) (FLU MIST) (MedImmune). Subsequently the patient experienced a possible anaphylactic reaction which included wheezing, shortness of breath, facial edema and facial mottling. The patient was stabilized and transported to the nearest hospital. No other information was available. This event did not occur at the reporting physicians office. This is one of several reports from the same reporter. Additional information has been requested.
Age: 2.0
Sex: M
Vaccine: VARCEL
Symptoms: Body temperature, Herpes zoster, Rash, Varicella zoster virus serology positive
Clinical narrative: Information has been received from a physician concerning a 2 year old male who on approximately 25-SEP-2007 was vaccinated with varicella virus vaccine live (Oka/Merck). It was reported that on 22-SEP-2007 he developed a rash on his left upper chest, neck, and upper back and was diagnosed with herpes zoster. On 25-SEP-2007, a five day course of therapy with acyclovir, 1.5 teaspoons four times a day was instituted. No fever was reported. It was reported that on 29-OCT-2007, a specimen for varicella zoster virus identification was obtained (results not reported). Current patient status was not reported. A product quality complaint was not reported. Further information was not available. Additional information has been requested.
Age: 8.0
Sex: F
Vaccine: VARCEL
Symptoms: Erythema, Rash
Clinical narrative: Information has been received from a physician concerning an 8 year old female who on 29-OCT-2007 was vaccinated with a second dose of varicella virus vaccine live (Oka/Merck). On 29-OCT-2007 the patient developed a localized rash around the injection site. It was reported that throughout the day the rash had spread all around patient's arm, and the arm was really red. The physician then advised the parents to take the patient to the emergency room. At the emergency room they said it was a localized rash and it would go away in a day or two. It was reported that the patient recovered on an unspecified date. A product quality complaint was not involved. Additional information has been requested.
Age: 1.3
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Herpes zoster, Injection site rash
Clinical narrative: Information has been received from a pharmacist concerning her 22 month old white daughter with a history of low haemogloblin and no drug allergies who on 29-MAR-2007 at 10:00 AM was vaccinated on left arm with a first dose of varicella virus vaccine live (Oka/Merck). Suspect secondary therapy on same day included a first dose on right arm of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (MSD). Concomitant therapy included sodium fluoride (+) vitamins (unspecified) (POLY-VI-FLOR DROPS). There was no illness at the time of vaccination. On 29-OCT-2007 at 7:00 PM the patient was diagnosed with shingles. Unspecified medical attention was sought. At the time of report the patient had not recovered. A product quality complaint was not involved. Additional information has been received from the pharmacist who stated that on 29-OCT-2007 the patient developed a rash on arm at injection site. On 12-NOV-2007 the patient recovered. No diagnostic laboratory tests were undertaken. No further information is expected.
Age: 93.0
Sex: F
Vaccine: VARCEL
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a registered nurse concerning a 93 year old female who on 29-OCT-2007 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck) instead of a a dose of zoster vaccine live (Oka/Merck). No adverse reaction reported. No medical attention was sought. A product quality complaint was not involved. Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Information has been received from a licensed visiting nurse concerning a 5-year-old male with no pertinent medical history or allergies who on 11-OCT-2007 was vaccinated subcutaneous in the right arm with a second 0.5 ml dose of varicella virus vaccine live (Oka/Merck) (lot # 658375/118U). There was no concomitant medication. On 12-OCT-2007 the parents of the child called the office stating the patient had redness and swelling above the injections site. The patient was seen in the office on 13-OCT-2007 and had 2 inches of swelling and redness above and below the injection site. The patient was treated with over the counter oral diphenhydramine hydrochloride (BENADRYL). No diagnostic labs were performed. At the time of the report the patient's status was unknown. A product quality complaint was not involved. Additional information has been requested.
Age: 1.5
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning an 18 month old patient who was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). On approximately 18-OCT-2007 "the patient broke out in varicella-like rash that looked like a breakthrough of chickenpox." Medical attention was sought through the physician. The outcome was unknown. There was no product quality complaint. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Cellulitis
Clinical narrative: Information has been received from a registered nurse concerning a patient who was vaccinated with a second dose of varicella virus vaccine live (Oka/Merck) (lot # 657758/0642U). On an unspecified date the patient experienced cellulitis. There were six cases of cellulitis with the same lot number. 2 cases were bad enough that they needed antibiotics. It was unknown whether medical attention was sought. The patient's outcome was unknown. A product quality complaint was not involved. This is one of several reports from the same source. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Cellulitis
Clinical narrative: Information has been received from a registered nurse concerning a patient who was vaccinated with their second dose of varicella virus vaccine live (Oka/Merck) (lot # 657758/0642U). On an unspecified date the patient experienced cellulitis. There were six cases of cellulitis with the same lot number. 2 cases were bad enough that the needed antibiotics. It was unknown whether medical attention was sought. The patient's outcome was unknown. A product quality complaint was not involved. This is one of several reports from the same source. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Cellulitis
Clinical narrative: Information has been received from a registered nurse concerning a patient who was vaccinated with their second dose of varicella virus vaccine live (Oka/Merck) (lot # 657758/0642U). On an unspecified date the patient experienced cellulitis. There were six cases of cellulitis with the same lot number. 2 cases were bad enough that they needed antibiotics. It was unknown whether medical attention was sought. The patient's outcome was unknown. A product quality complaint was not involved. This is one of several reports from the same source. Additional information has been requested.
Age: 28.0
Sex: F
Vaccine: VARCEL
Symptoms: Antibody test negative, Laboratory test
Clinical narrative: Information has been received from a 28-year-old female who in 2001 and 2002 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). In approximately 2004 (2 years later) the patient had a negative titer. "A titer 5 years after the vaccination was positive." The patient sought medical attention via an office visit. A product quality complaint was not involved. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Skin lesion
Clinical narrative: Information has been received from a health professional concerning an 8 year old black male who on 24-AUG-2000 was vaccinated with his first dose of varicella virus vaccine live (Oka/Merck) (lot# "1464A") in the left arm. On 22-OCT-2007 the patient developed lesions on his trunk, leg and scalp. No medical attention was sought. The patient was advised to use calamine every 2 hours. Subsequently, the patient recovered. Additional information has been requested.
Age: 1.6
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Lymphadenopathy, Pyrexia
Clinical narrative: Information has been received from a registered nurse concerning a 20 month old (previously reported as 6-month-old) female, with no pertinent medical history or allergies who on 19-OCT-2007 was vaccinated in the right thigh with her first dose of varicella virus vaccine live (Oka/Merck) (lot # 659115/1326U) and a first dose of measles-mumps-rubella vaccine (lot # 656527/0285U). The vaccines were given on the same day, but separate locations. The patient had a recent upper respiratory infection (URI) on 04-OCT-2007 at the time of vaccination. On 05-NOV-2007, the patient returned to the doctor's office with swollen lymph nodes (groin nodes) on the same sides as where the vaccine was given and fever. It was noted multiple nodes palpated in groin areas approximately 14 days post vaccination ("R>L"). No diagnostic laboratory test performed. At the time of the report the patient's status was unknown. Follow-up information received on 26-FEB-2008 indicated the patient recovered "Mid December". Additional information is not expected.
Age: 5.0
Sex: F
Vaccine: FLUX, VARCEL
Symptoms: Injection site erythema, Injection site pruritus, Injection site rash
Clinical narrative: Information has been received from a physician concerning a 4 or 5-year-old female who on 13-OCT-2007 was vaccinated in the arm with a second dose of varicella virus vaccine live (Oka/Merck) (lot# "08246"). Concomitant therapy included a dose of influenza virus vaccine (unspecified) which was administered in the other arm. On 14-OCT-2007 the patient developed a "half-dollar, circular sized, raised, red, itchy rash at the injection site" that lasted for about 3 to 4 days. Medical attention was no sought. Subsequently, the patient recovered on approximately 18-Oct-2007. No product quality complaint was involved. Additional information has been requested.
Age: 6.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a physician concerning a 7-year-old male student with no known drug allergies or birth defects who on 18-APR-2007 was vaccinated with a second dose of varicella virus vaccine live (Oka/Merck) (lot# 656688/0124U). There was no illness at the time of vaccination. On 01-NOV-2007, the patient experienced a breakthrough case of chickenpox. He was seen in the physician's office on 01-NOV-2007 because of small "crops" of different lesions from red papules to papulo-vesicular to vesicular to crusted, scattered on trunk, arms and legs. The patient had 50 pus filled and scabbed lesions. The patient recovered on an unspecified date. No product quality complaint was involved. Additional information is not expected.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Skin lesion, Varicella
Clinical narrative: Information has been received from a health professional concerning an 8 year old white male, with no medical history and no allergies, who on 12-JUL-2000 was vaccinated with a first dose of varicella virus vaccine live (Oka/Merck). There was no illness at the time of vaccination. On 25-OCT-2007 the patient was sent home by the school nurse who diagnosed chickenpox with less than 50 lesions. On 01-NOV-2007 the patient recovered. Medical attention was not sought. There were no laboratory or diagnostic tests performed. Additional information has been requested.
Age: 60.0
Sex: F
Vaccine: VARCEL
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: Information has been received from a medical assistant concerning a 60 year old female who on 06-NOV-2007 was vaccinated with a 0.5 mL dose of varicella virus vaccine live (Oka/Merck) instead of a dose of zoster vaccine live (Oka/Merck). It was reported that the product confusion happened because the names of both vaccines sounded the same to her. No adverse reaction was reported. A product quality complaint was not involved. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a pharmacist concerning a patient who on 07-NOV-2007 was vaccinated SC with a 0.5 ml dose of varicella virus vaccine live (Oka/Merck) instead of zoster vaccine live (Oka/Merck) for the prevention of shingles. This was a staff error and not product confusion. No adverse experience was reported. There was no product quality complaint involved. Additional information from the physician indicated that there was no adverse effect. No further information was provided. Additional information is not expected.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 information is not expected.
Age: 11.0
Sex: F
Vaccine: VARCEL
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a physician concerning an 11 year old female who in 2001 was vaccinated with varicella virus vaccine live (Oka/Merck). On 03-NOV-2007, the patient developed zoster. The physician did not provide any additional information. The patient sought unspecified medical treatment. At the time of the report, the patient has not recovered. Additional information has been requested.
Age: 27.0
Sex: F
Vaccine: VARCEL
Symptoms: Pruritus, Rash maculo-papular, Secondary transmission
Clinical narrative: Information has been received from a physician concerning her 61-year-old husband (who is also a physician) who was vaccinated with a dose of varicella virus vaccine live (Oka/Merck) on 02-Nov-2007. The husband did not develop a rash. On 06-NOV-2007, the reporting physician's 27 year-old daughter began to experience itching. She then developed a macular papular rash that came up in crops. The rash began on her limbs and spread to her trunk. The patient is being treated with Benadryl and will be seen by a dermatologist. At the time of the report the patient's status was not recovered. A product quality complaint was not involved. Additional information has been requested.
Age: 10.0
Sex: F
Vaccine: VARCEL
Symptoms: Erythema, Hypokinesia, Injection site vesicles, Pain in extremity, Pruritus
Clinical narrative: Information has been received from a registered nurse concerning a 10-year-old female with no pertinent medical history or allergies who on 05-NOV-2007 was vaccinated with a second dose of varicella virus vaccine live (Oka/Merck). There was no concomitant medication. On 07-NOV-2007, the patient developed a blister at the injection site; 15X14cm "erythematous"; "her arm was itchy", hurting and couldn't move; and a fever of 106 degrees after getting the second dose of varicella virus vaccine live (Oka/Merck). No diagnostic labs were performed. The patient sought unspecified medical attention. At the time of the report the patient's status was recovering. A product quality complaint was not involved. Additional information has been requested.
Age: 10.0
Sex: F
Vaccine: VARCEL
Symptoms: Pyrexia
Clinical narrative: Information has been received from a registered nurse concerning a 10-year-old female with no pertinent medical history or allergies who on 05-NOV-2007 was vaccinated with a second dose of varicella virus vaccine live (Oka/Merck). There was no concomitant medication. On 07-NOV-2007, the patient developed a blister at the injection site; 15X14cm "erythematous"; "her arm was itchy", hurting and couldn't move; and a fever of 106 degrees after getting the second dose of varicella virus vaccine live (Oka/Merck). No diagnostic labs were performed. The patient sought unspecified medical attention. At the time of the report the patient's status was recovering. A product quality complaint was not involved. Additional information has been requested.
Age: 62.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella zoster serology negative
Clinical narrative: Information has been received from a physician concerning a 62 year old female who "at age 51" (1996) reportedly received her first or only dose of varicella virus vaccine live (Oka/Merck). It was reported that the patient had never received a second dose of varicella virus vaccine live (Oka/Merck). In 2007, she had a negative titer for varicella virus. There was no reported adverse event. Medical attention sought and current patient status was not reported. A product quality complaint was not reported. The physician does not wish to be contacted about this issue.
Sex: M
Vaccine: VARCEL
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a physician concerning his son who in approximately 1997 was vaccinated with varicella virus vaccine live (Oka/Merck). About two or three months after receiving varicella virus vaccine live, the patient had developed shingles. Subsequently, the patient recovered from shingles. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Pyrexia, Varicella post vaccine
Clinical narrative: Information has been received from a nurse concerning a 10 year old male with no allergies and no reported medical history, who on 30-DEC-1997 received his first dose of varicella virus vaccine live (Oka/Merck). On 31-OCT-2007, the patient developed an itchy red rash and fever. He was seen by the physician in the office and on 01-NOV-2007, he was diagnosed with chickenpox. There were no laboratory or diagnostic test performed. Current patient status was not reported. A product quality complaint was not reported. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a consumer concerning her 13 month old son who on 08-AUG-2007 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). It was reported that the patient has chickenpox since vaccination and it was not improving. The consumer reported that her son never had a cold, fever or any symptoms of any illness before the vaccination. Unspecified medical attention was sought. A product quality complaint was not involved. No further information is expected.
Age: 4.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a registered nurse concerning a 5 year old male who on 15-SEP-2003 and 29-JUN-2007 was vaccinated SC with the first and second 0.5 mL doses of varicella virus vaccine live (Oka/Merck) (lot# "639445/0658L', 657455/0599U). On 08-NOV-2007 the patient developed 20 chickenpox lesions. Unspecified medical attention was sought. No treatment was noted. The patient was not to be recovering. There was no product quality complaint. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a registered nurse concerning a 9 year old female who on 14-FEB-1999 was vaccinated SC with a 0.5 mL dose of varicella virus vaccine live (Oka/Merck). On 08-NOV-2007, the patient developed chickenpox lesions over her entire body. No other symptoms were reported. Unspecified medical attention was sought. The patient was treated with loratadine. The patient was noted to be recovering. There was no product quality complaint. Additional information has been requested.
Age: 50.0
Sex: M
Vaccine: VARCEL
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: Information has been received from a physician concerning a 50 year old male who was vaccinated with a dose of varicella virus vaccine live (Oka/Merck) instead of a dose of zoster vaccine live (Oka/Merck). No adverse reactions were reported. A product quality complaint was not involved. Follow up information from a physician indicated that the 50 year old male patient did receive varicella virus vaccine live (Oka/Merck) instead of a dose of zoster vaccine live (Oka/Merck). It was reported that both vaccines were stored on the same shelf and it was a case of human error and not product confusion. The physician had no suggestions other than perhaps making the labels look a little less similar. The physician believed it was case of human error rather than poor labeling. Additional information has been requested.
Age: 1.1
Sex: M
Vaccine: VARCEL
Symptoms: Antibody test positive, Skin lesion, Varicella zoster virus serology positive
Clinical narrative: Information has been received from a registered nurse concerning a 6-year-old (also reported as 9.5 years old) male with no medical history or know allergies who on 22-APR-1999 was vaccinated subcutaneous in the left arm with his firs dose of varicella virus vaccine live (Oka/Merck) (lot # 628522/1843H). There were no illnesses at the time of vaccination. On 21-APR-2004 (at 09:20 hours) the patient developed 2 lesions on his neck and ankle suspicious of chickenpox. On an unspecified date, the patient had a serum varicella zoster virus antibody test and has varicella protection; additionally the patient recovered. This is one of several reports received from the same source. Additional information is not expected.
Age: 63.0
Sex: M
Vaccine: FLUX, PPV, VARCEL
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: Information has been received from a registered nurse concerning a 63 year old male with no pre-existing allergies, birth defects or medical conditions, who was vaccinated in the right arm at 10:00 AM with a first dose of varicella virus vaccine live (Oka/Merck) (lot number: 658763/1341U) instead of zoster vaccine live (Oka/Merck).  Concomitant medications included: influenza virus vaccine (unspecified) and pneumococcal 14v polysaccharide vaccine (manufacturer unknown). Nurse stated this was not a product quality complaint, staff error only. There was no adverse events recorded. There was no illness at time of vaccinations. There were no adverse events following prior vaccinations. No other information. Unspecified medical attention was sought. The patient was seen in the office. The outcome was reported as recovered. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Adverse event
Clinical narrative: Information has been received from a pharmacy technician reporting on her son who was vaccinated at a clinic with a dose of varicella virus vaccine live (Oka/Merck). In 1996 (11 years ago) the patient had an adverse experience with varicella virus vaccine live (Oka/Merck). A product quality complaint was not involved. This is one of two reports received from the same source. No further information is available.
Sex: U
Vaccine: VARCEL
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: Information has been received from a registered nurse concerning a patient who on 13-NOV-2007 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck) instead of zoster vaccine live (Oka/Merck). No adverse events were reported. Nurse stated this was not a product confusion, but the physician wrote down the drug name in the chart. No other information was available from the nurse. There was no product quality complaint. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a nurse immunization coordinator concerning a patient with sickle cell anemia who was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). On an unspecified date the patient developed shingles. There was no information regarding patient history of chickenpox or varicella virus vaccine live (Oka/Merck) immunization. The patient sought unspecified medical attention. At the time of the report the patient's status was unknown. A product quality complaint was not involved. Follow-up information was received  on 11-DEC-2007 indicating the patient did not received the second dose of varicella virus vaccine live (Oka/Merck). "Concern was raised because increase in shingles since beginning routine of second dose of varicella virus vaccine live (Oka/Merck)." this is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Herpes zoster ophthalmic
Clinical narrative: Information has been received from a nurse immunization coordinator concerning a patient who was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). On an unspecified date the patient had a severe case of shingles that involved a lesion on the optic nerve. There was no information regarding patient history of chickenpox or varicella virus vaccine live (Oka/Merck) immunization. The patient sough unspecified medical attention. At the time of the report the patient's status was unknown. A product quality complaint was not involved. Follow-up information was received on 11-DEC-2007 indicating the patient did not receive the second dose of varicella virus vaccine live (Oka/Merck). "Concern raised because increase in shingles since beginning routine of second dose of varicella virus vaccine live (Oka/Merck)." This is one of several reports received from the same source. Additional information has been requested.
Age: 10.0
Sex: F
Vaccine: MNQ, UNK, VARCEL
Symptoms: Back pain, Dehydration, Dizziness, Dyspnoea, Rash
Clinical narrative: Information has been received from a licensed practical nurse (LPN) concerning a 10-year-old female who on 06-Sep-2007 was vaccinated with a second dose of varicella virus vaccine live (Oka/Merck). Concomitant vaccination included meningococcal ACYW conj vaccine (dip toxoid) (MENACTRA) and "PEDAP". Subsequently, on an unspecified date, the patient developed dots that turned into a quarter (25 cents) sized raised rash. The rash started on the shoulders and arms. It spread to her neck, chest and legs. The condition progressed and the patient developed shortness of breath and dizziness which resulted in an Emergency Room visit on 19-Sep-2007. She is still complaining of a sore back and dehydration. No additional information was provided. This is one of several reports from the same source. Additional information has been requested.
Age: 10.0
Sex: F
Vaccine: MNQ, UNK, VARCEL
Symptoms: Skin disorder
Clinical narrative: Information has been received from a licensed practical nurse (LPN) concerning a 10-year-old female who on 06-Sep-2007 was vaccinated with a second dose of varicella virus vaccine live (Oka/Merck). Concomitant vaccination included meningococcal ACYW conj vaccine (dip toxoid) (MENACTRA) and "PEDAP". Subsequently, on an unspecified date, the patient developed dots that turned into a quarter (25 cents) sized raised rash. The rash started on the shoulders and arms. It spread to her neck, chest and legs. The condition progressed and the patient developed shortness of breath and dizziness which resulted in an Emergency Room visit on 19-Sep-2007. She is still complaining of a sore back and dehydration. No additional information was provided. This is one of several reports from the same source. Additional information has been requested.
Age: 13.0
Sex: F
Vaccine: TDAP, VARCEL
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: Information has been received from a physician concerning a 13 year old white female weighing 81.5 pounds and height of 59.25 inches with no previous medical history who on 27-AUG-2007 was vaccinated SC in the left arm with the second dose of varicella virus vaccine live (Oka/Merck) (Lot # 658177/1012U). On the same date the patient was also vaccinated IM in the left arm with the first dose of diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid (lot # AC52B016AA). On 28-AUG-2007 the patient developed red and painful site injection that lasted approximately 48 hours. The patient was treated with ibuprofen and cool compress. Subsequently, the patient recovered. There were no illness at time of vaccination. Additional information has been requested.
Sex: M
Vaccine: VARCEL
Symptoms: Urticaria
Clinical narrative: Information has been received from a physician concerning her son, who 2 years ago (2005), was vaccinated with varicella virus vaccine live (Oka/Merck) and developed hives after the vaccination. Medical attention sought was not reported. On an unspecified date the patient had recovered. Additional information has been requested.
Age: 1.0
Sex: U
Vaccine: VARCEL
Symptoms: Pyrexia, Skin lesion, Varicella
Clinical narrative: Information has been received from a physician concerning a 13 1/2 month old patient who at 12 months of age, received a single dose of varicella virus vaccine live (Oka/Merck). On an unspecified date while the patient was 13 1/2 months old, the patient developed chicken pox. It was reported that he had developed over 50 but less than 300 lesions and a fever for 4 to 5 days. It was reported that unspecified medical attention was sought. At the time of this report, the patient on an unspecified date had recovered. A quality complaint was not reported. Additional information has been requested.
Age: 1.03
Sex: F
Vaccine: VARCEL
Symptoms: Injection site rash, Rash generalised
Clinical narrative: Information has been received from a physician concerning a 12 month old patient who was vaccinated with a single dose of varicella virus vaccine live (Oka/Merck). It was reported that the patient developed a rash around the injection site after receiving the vaccine, and within 10-21 days the rash appeared on the torso, legs and arms. It was reported that unspecified medical attention was sought. At the time of this report, it was reported that the patient had recovered. A product quality complaint was not reported. Additional information has been requested.
Age: 12.0
Sex: M
Vaccine: VARCEL
Symptoms: Skin lesion, Varicella
Clinical narrative: Information has been received from a physician concerning a 12 year old male who in March 1998, was vaccinated with a dose of varicella virus vaccine live (Oka/Merck) and received a second dose in August 2005. In August 2007, the child was sent home from school with chicken pox and had more than 100 lesions all over his body. No fever was reported. Subsequently, the patient recovered from chicken pox. Unspecified medical attention was sought. No product quality complaint. Additional information has been requested.
Age: 12.0
Sex: F
Vaccine: TDAP, VARCEL
Symptoms: Blood glucose increased
Clinical narrative: Information has been received from a health professional concerning a patient (age and gender unknown) with diabetes who was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). Concomitant therapy included "Other vaccines within the same visit". Subsequently the patient experienced elevated blood sugars. Unspecified medical attention was sought. No product quality complaint. Follow-up information received from the registered nurse indicating that the patient is a 12 year old Asian female with Type II Diabetes Mellitus. The mother reported that blood sugars were more out of control than normal approximately 1 week (15-Nov-2007) after receiving the following immunizations: On 09-NOV-2007 was vaccinated with varicella virus vaccine live (Oka/Merck) (lot# 658964/1466U) subcutaneously in the left arm and diphtheria toxoid (+) pertussis acellular 5-component vaccine (+) tetanus toxoid (ADACEL) (lot# AC5280210B) intramuscularly in the right arm. On 06-Nov-2007, the patient received meningococcal ACYW conj vaccine (dip toxoid) (MENACTRA) (lot# U2540AA) intramuscularly in the right arm, influenza virus whole virion 3v vaccine inactivated (FLUZONE (influenza virus whole virion 3v vaccine inactivated)(lot# U2448AA) intramuscularly in the left arm and tuberculin purified protein derivative (TUBERSOL) (lot# C2805AA) intradermally. She wondered if there was a correlation. No illness at the time of vaccination. The patient recovered on an unknown date. No further information is expected.
Age: 11.0
Sex: F
Vaccine: FLU3, VARCEL
Symptoms: Blood pressure decreased, Dizziness, Pain, Pallor
Clinical narrative: Information has been received from a physician concerning an 11 year old 79 1/2 lb. 55 1/2 in. female who on 09-NOV-2007 at 11:00 hours received her second dose of varicella virus vaccine live (Oka/Merck) (lot#659156/1367U). Concomitant vaccination included Fluzone (lot # U2476HA). There was no reported illness at the time of vaccination. On 09-NOV-2007, after receiving the vaccination, it was reported that the patient felt something shooting down her upper extremity, felt dizzy and was pale. Her pulse rate was reported as 80 to 90 with a blood pressure of 60/42. A repeat blood pressure in 10 minutes was 72/48. After 15 minutes, her blood pressure was 90/70. Reported treatment measures were oral fluids (water) and to rest. It was reported that she left the physicians office after about 30 minutes. It was reported she presented on 10-NOV-2007 to the physicians office with dizziness. It was reported that on 10-NOV-2007, her blood pressure was 80/60. Follow up information from the physician indicated that on 15-NOV-2007, she had recovered. A product quality complaint was not reported. Additional information has been requested.
Age: 2.0
Sex: M
Vaccine: VARCEL
Symptoms: Skin lesion
Clinical narrative: Information has been received from a registered nurse concerning an 11 year old male who on 07-APR-1998 at the age of 2 years was vaccinated with varicella virus vaccine live (Oka/Merck) (Lot# 625128/0062H) first dose in the left thigh. The patient had no preexisting medical conditions. On 09-NOV-2007, the patient developed multiple lesions on trunk, hairline and arms. The patient was treated with over the counter comfort measures by the physician and recovered on an unspecified date. Additional information has been requested.
Age: 12.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash
Clinical narrative: Information has been received from a registered nurse concerning a 12 year old male with no pertinent medical history and no known allergies who was vaccinated with a first dose of varicella virus vaccine live (Oka/Merck) in 1999, a second dose of varicella virus vaccine live (Oka/Merck) in AUG 2007, and a third dose of varicella virus vaccine live (Oka/Merck) on 08 NOV 2007 (Lot # 658405/1076U). On 14-NOV-2007 the patient's mother reported that the patient had developed rash in the groin, buttocks and chest. At the time of reporting the patient had not yet recovered, and is scheduled for a follow up visit. There were no lab diagnostic studies performed. Additional information has been requested.
Age: 1.5
Sex: F
Vaccine: VARCEL
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a physician concerning a 6 year old female who on 13-AUG-2002 was vaccinated subcutaneously with a first dose of varicella virus vaccine live (Oka/Merck). Medical attention was sought. On 17-AUG-2007, the patient presented to the physician's office and was subsequently diagnosed with shingles. The physician reported that the patient "cleared up and was fine". The date of recovery was not reported. There was no product quality complaint. Additional information has been requested.
Age: 47.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Accidental exposure, Oral herpes
Clinical narrative: Information has been received from a health professional concerning herself, a 47 year old female, with a history of eczema who on 15-NOV-2007 was splashed in the face with either  measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (lot# 657249/0526U) or varicella virus vaccine live (Oka/Merck) (Lot# 658588/1273U). The nurse was not sure which vaccine she was splashed with because they were both drawn up into a syringe. The vaccine did not splash into her eyes. The nurse also reported that she is developing a cold sore on her lip in the area of contact with the vaccine. The patient's outcome was not reported. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Rash, Skin lesion, Varicella post vaccine
Clinical narrative: Information has been received from a registered nurse and a consumer concerning a 10 year old female who on 09-JUL-1998 was vaccinated with the first 0.5 ml dose of varicella virus vaccine live (Oka/Merck) (lot# 625047/1574E). On 04-OCT-2007 during follow-up for the patient's brother for a chicken pox outbreak (WAES# 0711USA03442), the parents reported that their daughter also developed a chicken pox outbreak, with less than 50 lesions (reported by nurse as varicella outbreak post vaccination with varicella virus vaccine live (Oka/Merck)). It was unknown if the patient had a fever. The nurse contacted the county health department for medical attention. Treatment was also unknown. Subsequently, the patient recovered quickly and completely. There was no product quality complaint. Follow-up information from the reporting registered nurse indicated that the 10 year old Hispanic female did not have a fever along with the rash onset of less than 50 lesions from a varicella outbreak. The patient was noted to be recovered before 02-NOV-2007. This is one of four reports from the same source. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a registered nurse and a consumer concerning a 10 year old male with no pertinent medical history who on 09-JUL-1998 was vaccinated with the first 0.5 mL dose of varicella virus vaccine live (Oka/Merck) (lot# 625047/1574E). On 15-OCT-2007, the patient developed chickenpox. On 18-OCT-2007, the parent of the child contacted the school nurse stating the child had chickenpox lesions on the back, abdomen, face, arms and legs, which the nurse described as severity level 1 (50-100 lesions) (reported by nurse as varicella outbreak post vaccination with varicella virus vaccine live (Oka/Merck). It was unknown if the child had a fever. Treatment was also unknown. On 02-NOV-2007 via follow-up the child was noted to be recovering and had less than 50 lesions. There was no product quality complaint. This is one of four reports from the same source. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Pyrexia, Varicella post vaccine
Clinical narrative: Information has been received from a registered nurse concerning an approximately 11 year old male who on 03-OCT-1997 was vaccinated with a 0.5 mL dose of varicella virus vaccine live (Oka/Merck) (lot# 622625/0085E). Subsequently, the patient developed chickenpox. On approximately 18-OCT-2007 the school contacted the health department to describe the child's chickenpox as severity level 2, categorized as 50 to 500 lesions from the waist up (reported by nurse as varicella outbreak post vaccination with varicella virus vaccine live (Oka/Merck). The child also had a fever. Subsequently, the patient recovered from chickenpox with no problems. There was no product quality complaint. Follow-up information from the reporting registered nurse indicated that the 11 year old male developed chickenpox characterized by a rash of 50 to 500 lesions on the face and truck and presence of fever on 16-OCT-2007 (also reported as approximately 18-OCT-2007). The patient was noted to be recovered before 05-NOV-2007. This is one of four reports from the same source. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Pyrexia, Skin lesion, Varicella post vaccine
Clinical narrative: Information has been received from a registered nurse and a physician concerning a 7 year old female who on 07-JUN-2001 was vaccinated with a 0.5 ml dose of varicella virus vaccine live (Oka/Merck) (lot# 635948/1333K). On 06-OCT-2007 the patient experienced a fever and developed less than 50 lesions on her face, back and underneath both arms (reported by nurse as varicella outbreak post vaccination with varicella virus vaccine live (Oka/Merck)). The child's primary physician contacted the county health department for medical attention. Subsequently, the patient fully recovered. There was no product quality complaint. This is one of four reports from the same source. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Cellulitis
Clinical narrative: Information has been received from a registered nurse concerning a patient who on 23-OCT-2007 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck) (Lot # 658932/1343U). It was reported that the patient presented with cellulitis. A product quality complaint was not involved. Additional information has been requested. This is one of several reports received from the same source.
Age: 7.0
Sex: U
Vaccine: VARCEL
Symptoms: Rash vesicular
Clinical narrative: Information has been received from a physician assistant concerning a 7-year-old patient with no pertinent medical history or allergies who on 14-AUG-2007 was vaccinated subcutaneous with a second dose of varicella virus vaccine live (Oka/Merck) (lot # "0856U"). There was no concomitant medication. On an unspecified date the patient developed a varicella-like rash of 50 lesions or less. The patient sought medical attention via an office exam on 12-SEP-2007. No diagnostic labs were performed. On an unspecified date the patient recovered. A product quality complaint was not involved. This is one of several reports received from the same source. Additional information has been requested.